Clinical trial Recruiting at 1 site Observational Ages 18 and up

Sleep apnea biomarkers and CPAP use after diagnosis

Official title: Impact of Obstructive Sleep Apnea Biomarkers on Adherence to Continuous Positive Airway Pressure: Role of Pulse Wave Amplitude Drop Index, Hypoxic Burden, and Heart Rate Variability

Run by Clinique du Millenaire · NCT07792746 · Data updated 2026-11-12

This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorClinique du Millenaire
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedDecember 31, 2026
Study endsSeptember 30, 2027
Registry record updatedAugust 28, 2026
Trial IDNCT07792746 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with newly diagnosed obstructive sleep apnea who are indicated for CPAP and provide informed consent.

Probably not a fit

Patients unlikely to benefit include those with prior CPAP use in the last 3 months or conditions that strongly affect adherence or contraindicate CPAP.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter observational cohort study of adults with newly diagnosed obstructive sleep apnea who are prescribed CPAP. Baseline data include demographic details, medical history, symptom questionnaires, and biomarkers derived from initial sleep studies, such as hypoxic burden, pulse wave amplitude drop index, and heart rate response. CPAP adherence is measured at roughly 12 weeks, with additional follow-up for clinical characteristics, quality of life, and potential biomarker changes if a follow-up sleep study is performed as part of routine care. The primary aim is to examine associations between baseline biomarkers and CPAP adherence, while secondary analyses explore biomarker distributions across clinical factors and their relationship with symptoms and outcomes.

Why it matters

Potential benefit: If successful, biomarkers could help predict which patients are most likely to adhere to CPAP and guide personalized management.

How similar studies have gone: Prior work in sleep apnea biomarkers has shown associations with disease severity and treatment response, but prospective links to CPAP adherence are less established and remain exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newly diagnosed obstructive sleep apnea with an indication for continuous positive airway pressure therapy
* Age older than 18 years
* Written informed consent obtained

Exclusion Criteria:

* Continuous positive airway pressure treatment during the preceding 3 months
* Medical contraindication to continuous positive airway pressure therapy
* Concomitant condition likely to affect adherence to continuous positive airway pressure, including severe cognitive impairment or an unstable psychiatric disorder

Where it's running

  • Clinique Millenaire
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.